...
首页> 外文期刊>Current topics in medicinal chemistry >Natural products as sources of new lead compounds for the treatment of Alzheimer's disease.
【24h】

Natural products as sources of new lead compounds for the treatment of Alzheimer's disease.

机译:天然产物可作为治疗阿尔茨海默氏病的新型先导化合物的来源。

获取原文
获取原文并翻译 | 示例

摘要

Alzheimer's disease (AD) is the most prevalent form of dementia and affects approximately 24 million people worldwide. One possible approach for the treatment of this disease is the restoration of the level of acetylcholine (ACh) through the inhibition of acetylcholinesterase (AChE) with reversible inhibitors. Naturally occurring alkaloids are an important source of AChE inhibitors. Galantamine and huperzine A have been used for the clinical treatment of AD patients. In this review, we summarise the natural products and their derivatives that were reported to act as AChE inhibitors for the treatment of AD in 2010-2013. Several characteristics were summarised from the literature results: 1) Amongst all of the natural products with AChE inhibitory activity, alkaloids appear to be the most promising compound class. 2) Coumarins, flavonoids, stilbenes, and other natural products are also important AChE inhibitors from natural products. Among these inhibitors, 146 (IC50 = 0.573 μM) was identified as the most potent AChE inhibitor. 3) A coumarin derivative (117, IC50 = 0.11 nM) exhibited more than 100-fold superior activity compared with the reference drug donepezil hydrochloride (IC50 = 14 nM). In conclusion, natural products and their derivatives are promising leads for the development of new drugs for the future treatment of AD.
机译:阿尔茨海默氏病(AD)是痴呆症最普遍的形式,在全球范围内影响约2400万人。治疗该疾病的一种可能方法是通过用可逆抑制剂抑制乙酰胆碱酯酶(AChE)来恢复乙酰胆碱(ACh)的水平。天然生物碱是AChE抑制剂的重要来源。加兰他敏和石杉碱甲已用于AD患者的临床治疗。在这篇综述中,我们总结了据报道在2010-2013年间可作为AChE抑制剂治疗AD的天然产物及其衍生物。从文献结果中总结出几个特征:1)在所有具有AChE抑制活性的天然产物中,生物碱似乎是最有前途的化合物类别。 2)香豆素,类黄酮,芪和其他天然产物也是来自天然产物的重要AChE抑制剂。在这些抑制剂中,有146种(IC50 = 0.573μM)被确定为最有效的AChE抑制剂。 3)与参考药物盐酸多奈哌齐(IC50 = 14 nM)相比,香豆素衍生物(117,IC50 = 0.11 nM)表现出超过100倍的优越活性。总之,天然产物及其衍生物是开发用于治疗AD的新药的有希望的先导。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号